Clene Inc. SEC filings CLNN
Clene Inc. has 707 filings in SEC EDGAR's recent list, going back to Sep 10, 2020. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SD | Specialized disclosure (conflict minerals) | May 22, 2026 | — |
| 25-NSE | Delisting notice | Dec 30, 2025 | — |
| EFFECT | Filing | Sep 12, 2025 | — |
| CORRESP | Letter to the SEC | Sep 10, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2025 | — |
| SD | Specialized disclosure (conflict minerals) | May 16, 2025 | — |
| EFFECT | Filing | Apr 25, 2025 | — |
| CORRESP | Letter to the SEC | Apr 23, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 27, 2025 | — |
| EFFECT | Filing | Feb 3, 2025 | — |
| CORRESP | Letter to the SEC | Jan 31, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 30, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 16, 2025 | — |
| CORRESP | Letter to the SEC | Jan 2, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 6, 2024 | — |
| EFFECT | Filing | Nov 22, 2024 | — |
| CORRESP | Letter to the SEC | Nov 20, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2024 | — |
| D | Filing | Oct 9, 2024 | — |
| SD | Specialized disclosure (conflict minerals) | Jun 3, 2024 | — |
| EFFECT | Filing | Oct 6, 2023 | — |
| CORRESP | Letter to the SEC | Oct 4, 2023 | — |
| CORRESP | Letter to the SEC | Sep 29, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 27, 2023 | — |
| SD | Specialized disclosure (conflict minerals) | May 19, 2023 | — |
| PRER14A | Filing | Mar 22, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 13, 2023 | — |
| EFFECT | Filing | Apr 26, 2022 | — |
| CORRESP | Letter to the SEC | Apr 22, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 18, 2022 | — |
| EFFECT | Filing | Jan 13, 2022 | — |
| EFFECT | Filing | Aug 2, 2021 | — |
| CORRESP | Letter to the SEC | Jul 30, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 28, 2021 | — |
| D | Filing | May 26, 2021 | — |
| EFFECT | Filing | Apr 19, 2021 | — |
| CORRESP | Letter to the SEC | Apr 16, 2021 | — |
| CORRESP | Letter to the SEC | Apr 7, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 5, 2021 | — |
| CORRESP | Letter to the SEC | Mar 29, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 1, 2021 | — |
| 8-A12B/A | Amendment no. 1 to form 8-a12b | Feb 10, 2021 | — |
| CERT | Filing | Dec 30, 2020 | — |
| 8-A12B | For registration of certain classes | Dec 30, 2020 | — |
| SEC STAFF LETTER | Filing | Dec 18, 2020 | — |
| EFFECT | Filing | Dec 18, 2020 | — |
| CORRESP | Letter to the SEC | Dec 16, 2020 | — |
| CORRESP | Letter to the SEC | Dec 7, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 1, 2020 | — |
| CORRESP | Letter to the SEC | Nov 18, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 5, 2020 | — |
| SEC STAFF LETTER | Filing | Oct 26, 2020 | — |
| CORRESP | Letter to the SEC | Oct 19, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 13, 2020 | — |
Showing 54 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CLNN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Salt Lake City, UT
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1822791
- Former names
- Chelsea Worldwide Inc. (until Dec 18, 2020)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.